This approach helps in silencing CTLA-4 and PD-1 genes, resulting in the upregulation of CD8 T cells by creating a pro-immune modulatory tumor environment, gearing the ability of T cells towards tumor recognition. This evidence concerns the gene CTLA4 and neoplasm.